Effectiveness of Ad26.COV2.S Vaccine vs BNT162b2 Vaccine for COVID-19 Hospitalizations

This comparative effectiveness research study examines the effectiveness of full vaccination with Ad26.COV2.S vs BNT162b2 against COVID-19–related hospitalization.

Detalles Bibliográficos
Autores principales: Botton, Jérémie, Semenzato, Laura, Jabagi, Marie-Joëlle, Baricault, Bérangère, Weill, Alain, Dray-Spira, Rosemary, Zureik, Mahmoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892225/
https://www.ncbi.nlm.nih.gov/pubmed/35234883
http://dx.doi.org/10.1001/jamanetworkopen.2022.0868
Descripción
Sumario:This comparative effectiveness research study examines the effectiveness of full vaccination with Ad26.COV2.S vs BNT162b2 against COVID-19–related hospitalization.

Ejemplares similares